# Dexmedetomidine in IVRA

> **NCT05123170** · PHASE4 · COMPLETED · sponsor: **Menoufia University** · enrollment: 90 (actual)

## Conditions studied

- Regional Anesthesia Morbidity

## Interventions

- **DRUG:** Dexmedetomidine Injectable Solution [Dexdomitor]
- **DRUG:** Lidocaine IV

## Key facts

- **NCT ID:** NCT05123170
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-28
- **Primary completion:** 2021-03-25
- **Final completion:** 2021-06-20
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05123170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05123170, "Dexmedetomidine in IVRA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05123170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*